Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

U.N., U.S. Re-Evaluate HIV/AIDS Treatment Targets

May 27, 2011

Ahead of the U.N. High Level Meeting on AIDS, scheduled for June 8-10 in New York, "public-health leaders face a paradox: New evidence suggests the epidemic can finally be controlled, but that would demand increased spending at a time of severe global budget restraints," the Wall Street Journal reports. Preliminary estimates from the Kaiser Family Foundation and UNAIDS show last year donor funding for HIV/AIDS fell for the first time since the beginning of the epidemic, according to the newspaper.

Advertisement

The U.N. meeting will consider whether to set targets for how many people to put on treatment by 2015, but "such targets will not be met unless new money is found to buy medicine for more people after the 2010 funding drop," Wall Street Journal writes. Recently released results of an NIH-sponsored trial showing early antiretroviral therapy drastically reduces HIV transmission are complicating the issue, because when combined with other prevention strategies, many experts believe widespread HIV treatment "could turn the tide on an epidemic that currently infects more than 2.5 million people each year," the newspaper notes.

In the U.S., the Obama administration is in the midst of "a 'rigorous' internal dialogue to determine what targets and commitments would be needed to get enough people on treatment to reverse the epidemic, and what the U.S. contribution should be," according to U.S. Global AIDS Coordinator Ambassador Eric Goosby, Wall Street Journal reports. The U.S. goal currently is to treat four million people worldwide by 2013 (McKay/Schoofs, 5/27).

"We need to ask ourselves if this indeed presents an opportunity for us to be more effective in preventing new [HIV] infections," Goosby told journalists on Wednesday about the treatment as prevention research, NPR's health blog "Shots" reports. In addition to the cost, Goosby said ethical issues still exist about whether people living with HIV at any stage should have access to medications or if those with late-stage disease, pregnant women or children should be prioritized. "What I'm now committed to doing is shepherding the dialogue within the U.S. government – to go quickly, but I want to do it consciously," he said (Knox, 5/26).

Back to other news for May 2011


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Treating HIV-Infected People With Antiretrovirals Reduces Transmission to Partners by 96%, Study Finds
HPTN 052 Results -- Another Win for Early HIV Therapy
Major Opinion on Major HIV/AIDS Crisis: Why Isn't the U.S. Funding More Treatment for Its Citizens?
More on HIV Treatment in the Developing World
More News on Global HIV/AIDS
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement